Cargando…
Gene Expression Profiling of the Response to Interferon Beta in Epstein-Barr-Transformed and Primary B Cells of Patients with Multiple Sclerosis
The effects of interferon-beta (IFN-β), one of the key immunotherapies used in multiple sclerosis (MS), on peripheral blood leukocytes and T cells have been extensively studied. B cells are a less abundant leukocyte type, and accordingly less is known about the B cell-specific response to IFN-β. To...
Autores principales: | Khsheibun, Rana, Paperna, Tamar, Volkowich, Anat, Lejbkowicz, Izabella, Avidan, Nili, Miller, Ariel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099420/ https://www.ncbi.nlm.nih.gov/pubmed/25025430 http://dx.doi.org/10.1371/journal.pone.0102331 |
Ejemplares similares
-
Internet Usage by Patients with Multiple Sclerosis: Implications to Participatory Medicine and Personalized Healthcare
por: Lejbkowicz, Izabella, et al.
Publicado: (2010) -
Interferon-Beta Induces Distinct Gene Expression Response Patterns in Human Monocytes versus T cells
por: Henig, Noa, et al.
Publicado: (2013) -
Tight junction proteins expression and modulation in immune cells and multiple sclerosis
por: Mandel, Ilana, et al.
Publicado: (2012) -
Multiple Sclerosis-Associated Gut Microbiome in the Israeli Diverse Populations: Associations with Ethnicity, Gender, Disability Status, Vitamin D Levels, and Mediterranean Diet
por: Nitzan, Zehavit, et al.
Publicado: (2023) -
Serum IgG levels to Epstein-Barr and measles viruses in patients with multiple sclerosis during natalizumab and interferon beta treatment
por: Persson Berg, Linn, et al.
Publicado: (2022)